277 related articles for article (PubMed ID: 23239800)
1. In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp.
Wang Z; Niu J; Wang S; Lv Y; Wu Q
Clin Vaccine Immunol; 2013 Feb; 20(2):174-80. PubMed ID: 23239800
[TBL] [Abstract][Full Text] [Related]
2. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
3. Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice.
Tibor A; Jacques I; Guilloteau L; Verger JM; Grayon M; Wansard V; Letesson JJ
Infect Immun; 1998 Nov; 66(11):5561-4. PubMed ID: 9784574
[TBL] [Abstract][Full Text] [Related]
4. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
[TBL] [Abstract][Full Text] [Related]
5. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.
Kahl-McDonagh MM; Ficht TA
Infect Immun; 2006 Jul; 74(7):4048-57. PubMed ID: 16790778
[TBL] [Abstract][Full Text] [Related]
7. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
[TBL] [Abstract][Full Text] [Related]
8. Protective properties of rifampin-resistant rough mutants of Brucella melitensis.
Adone R; Ciuchini F; Marianelli C; Tarantino M; Pistoia C; Marcon G; Petrucci P; Francia M; Riccardi G; Pasquali P
Infect Immun; 2005 Jul; 73(7):4198-204. PubMed ID: 15972510
[TBL] [Abstract][Full Text] [Related]
9. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
[TBL] [Abstract][Full Text] [Related]
10. Antigenic, immunologic and genetic characterization of rough strains B. abortus RB51, B. melitensis B115 and B. melitensis B18.
Adone R; Muscillo M; La Rosa G; Francia M; Tarantino M
PLoS One; 2011; 6(10):e24073. PubMed ID: 22065984
[TBL] [Abstract][Full Text] [Related]
11. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
Truong QL; Cho Y; Kim K; Park BK; Hahn TW
Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
[TBL] [Abstract][Full Text] [Related]
12. Brucella abortus S19 vaccine protects dairy cattle against natural infection with Brucella melitensis.
van Straten M; Bardenstein S; Keningswald G; Banai M
Vaccine; 2016 Nov; 34(48):5837-5839. PubMed ID: 27771184
[TBL] [Abstract][Full Text] [Related]
13. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model.
Uslu A; Erganis O
Mol Immunol; 2021 May; 133():44-52. PubMed ID: 33631554
[TBL] [Abstract][Full Text] [Related]
14. Rough brucella strain RM57 is attenuated and confers protection against Brucella melitensis.
Feng Y; Peng X; Jiang H; Peng Y; Zhu L; Ding J
Microb Pathog; 2017 Jun; 107():270-275. PubMed ID: 28390976
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model.
Monreal D; Grilló MJ; González D; Marín CM; De Miguel MJ; López-Goñi I; Blasco JM; Cloeckaert A; Moriyón I
Infect Immun; 2003 Jun; 71(6):3261-71. PubMed ID: 12761107
[TBL] [Abstract][Full Text] [Related]
16. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model.
Dabral N; Burcham GN; Jain-Gupta N; Sriranganathan N; Vemulapalli R
PLoS One; 2019; 14(3):e0213587. PubMed ID: 30856219
[TBL] [Abstract][Full Text] [Related]
18. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.
Solanki KS; Varshney R; Qureshi S; Thomas P; Singh R; Agrawal A; Chaudhuri P
Int Immunopharmacol; 2021 Jan; 90():107148. PubMed ID: 33189614
[TBL] [Abstract][Full Text] [Related]
19. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.
el Idrissi AH; Benkirane A; el Maadoudi M; Bouslikhane M; Berrada J; Zerouali A
Rev Sci Tech; 2001 Dec; 20(3):741-7. PubMed ID: 11732416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
